- Investing Ideas
- /
- U.S. Large Cap High Growth Potential
U.S. Large Cap High Growth Potential
UPDATED Aug 10, 2022
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
226 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| FISFidelity National Information Services | US$99.88 | -4.1% | -25.4% | US$60.7b | US$124.60 | PE71.8x | E23.3% | 1.9% | Software | ||
| GPNGlobal Payments | US$132.60 | 1.9% | -21.8% | US$36.8b | US$168.70 | PE477.8x | E104.3% | 0.8% | Software | ||
| GOOGLAlphabet | US$119.70 | 1.4% | -12.2% | US$1.6t | US$142.56 | PE21.7x | E12.9% | n/a | Media | ||
| BALLBall | US$57.48 | -21.1% | -35.8% | US$18.1b | US$65.89 | PE24.2x | E16.5% | 1.4% | Materials | ||
| DOXAmdocs | US$88.17 | 2.9% | 16.6% | US$10.8b | US$94.20 | PE19.9x | E7.4% | 1.8% | Software | ||
| CRLCharles River Laboratories International | US$226.52 | 2.3% | -43.3% | US$11.5b | US$280.83 | PE26x | E17.7% | n/a | Pharmaceuticals & Biotech | ||
| SYKStryker | US$219.20 | 1.5% | -14.9% | US$82.9b | US$236.33 | PE39.9x | E14.8% | 1.3% | Healthcare | ||
| TMUST-Mobile US | US$144.84 | 0.8% | 0.2% | US$181.6b | US$174.72 | PE105.7x | E37.2% | n/a | Telecom | ||
| REXRRexford Industrial Realty | US$66.80 | 2.5% | 9.8% | US$11.7b | US$78.88 | PB2.1x | E19.3% | 1.9% | Real Estate | ||
| MOHMolina Healthcare | US$329.77 | 0.5% | 32.0% | US$19.2b | US$341.44 | PE25.5x | E15.3% | n/a | Healthcare |